Joseph A. Vissers

305 Grattan St
Melbourne, VIC 3000, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Whole genome and exome sequencing of pancreatic neuroendocrine tumour to investigate PRRT response.

Whole genome and exome sequencing of pancreatic neuroendocrine tumour to investigate PRRT response.

Journal: Endocrine-related cancer

Published: April 20, 2026

Pathologist-initiated whole genome and transcriptome sequencing demonstrates diagnostic utility in resolving difficult-to-diagnose tumors.

Pathologist-initiated whole genome and transcriptome sequencing demonstrates diagnostic utility in resolving difficult-to-diagnose tumors.

Journal: Genome medicine

Published: March 12, 2025

Perioperative IDH inhibition in treatment-naive IDH-mutant glioma: a pilot trial.

Perioperative IDH inhibition in treatment-naive IDH-mutant glioma: a pilot trial.

Journal: Nature medicine

Published: September 24, 2024

Whole genome sequencing improves tissue-of-origin diagnosis and treatment options for cancer of unknown primary.

Whole genome sequencing improves tissue-of-origin diagnosis and treatment options for cancer of unknown primary.

Journal: Nature communications

Published: August 08, 2024

Neoadjuvant triplet immune checkpoint blockade in newly diagnosed glioblastoma.

Neoadjuvant triplet immune checkpoint blockade in newly diagnosed glioblastoma.

Journal: Nature medicine

Published: July 24, 2024

Clinical Impact of Comprehensive Molecular Profiling in Adolescents and Young Adults with Sarcoma.

Clinical Impact of Comprehensive Molecular Profiling in Adolescents and Young Adults with Sarcoma.

Journal: Journal of personalized medicine

Published: November 30, 2023

A Matched Molecular and Clinical Analysis of the Epithelioid Haemangioendothelioma Cohort in the Stafford Fox Rare Cancer Program and Contextual Literature Review.

A Matched Molecular and Clinical Analysis of the Epithelioid Haemangioendothelioma Cohort in the Stafford Fox Rare Cancer Program and Contextual Literature Review.

Journal: Cancers

Published: July 27, 2023

The JNK and Hippo pathways control epithelial integrity and prevent tumor initiation by regulating an overlapping transcriptome.

The JNK and Hippo pathways control epithelial integrity and prevent tumor initiation by regulating an overlapping transcriptome.

Journal: Current biology : CB

Published: June 29, 2023

Targeting homologous recombination deficiency in uterine leiomyosarcoma.

Targeting homologous recombination deficiency in uterine leiomyosarcoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: February 14, 2023

A rare diagnostically challenging case of CIC-DUX4 sarcoma arising in the neck.

A rare diagnostically challenging case of CIC-DUX4 sarcoma arising in the neck.

Journal: Pathology

Published: January 10, 2022

Novel RET Fusion RET-SEPTIN9 Predicts Response to Selective RET Inhibition With Selpercatinib in Malignant Pheochromocytoma.

Novel RET Fusion RET-SEPTIN9 Predicts Response to Selective RET Inhibition With Selpercatinib in Malignant Pheochromocytoma.

Journal: JCO precision oncology

Published: January 07, 2022

The PP2A-Integrator-CDK9 axis fine-tunes transcription and can be targeted therapeutically in cancer.

The PP2A-Integrator-CDK9 axis fine-tunes transcription and can be targeted therapeutically in cancer.

Journal: Cell

Published: June 23, 2020

Showing 1-12 of 21

Last Updated: 09/26/2026